Overview
NVEC market data
Price History
NVEC price chart · 1M
- O
- 110.20
- H
- 110.20
- L
- 110.20
- C
- 110.20
- Vol
- 1,706.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $110.20
- Previous Close
- $110.29
- Day High
- $110.20
- Day Low
- $110.20
- 52 Week High
- $133.14
- 52 Week Low
- $83.12
- 7 Day Return
- +2.54%
- 30 Day Return
- +12.70%
- 90 Day Return
- +11.35%
- 1 Year Return
- +1.32%
- Daily Notional Volume
- $188K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 29.51 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.14 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.31 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 57.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $57.21 – $135.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $531.6M · P/B 5.44 · P/S 17.01.
Company News
10 captured
8-K filing — NVE CORP /NEW/ (NVEC)SEC EDGAR ·
Jim Cramer Calls Summit Therapeutics A 'Great Spec,' Recommends Buying This Consumer Cyclical StockBenzinga ·
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About YetBenzinga ·
Earnings Scheduled For July 22, 2026Benzinga ·